244 related articles for article (PubMed ID: 11990780)
1. Drug resistance in epilepsy: the role of the blood-brain barrier.
Abbott NJ; Khan EU; Rollinson CM; Reichel A; Janigro D; Dombrowski SM; Dobbie MS; Begley DJ
Novartis Found Symp; 2002; 243():38-47; discussion 47-53, 180-5. PubMed ID: 11990780
[TBL] [Abstract][Full Text] [Related]
2. Subcellular localization of transporters along the rat blood-brain barrier and blood-cerebral-spinal fluid barrier by in vivo biotinylation.
Roberts LM; Black DS; Raman C; Woodford K; Zhou M; Haggerty JE; Yan AT; Cwirla SE; Grindstaff KK
Neuroscience; 2008 Aug; 155(2):423-38. PubMed ID: 18619525
[TBL] [Abstract][Full Text] [Related]
3. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
Löscher W; Luna-Tortós C; Römermann K; Fedrowitz M
Curr Pharm Des; 2011; 17(26):2808-28. PubMed ID: 21827408
[TBL] [Abstract][Full Text] [Related]
4. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of brain expression of P-glycoprotein in MRP2-deficient TR(-) rats resembles seizure-induced up-regulation of this drug efflux transporter in normal rats.
Hoffmann K; Löscher W
Epilepsia; 2007 Apr; 48(4):631-45. PubMed ID: 17437408
[TBL] [Abstract][Full Text] [Related]
6. Influence of multidrug resistance (MDR) proteins at the blood-brain barrier on the transport and brain distribution of enaminone anticonvulsants.
Cox DS; Scott KR; Gao H; Raje S; Eddington ND
J Pharm Sci; 2001 Oct; 90(10):1540-52. PubMed ID: 11745712
[TBL] [Abstract][Full Text] [Related]
7. The antiepileptic drug lamotrigine is a substrate of mouse and human breast cancer resistance protein (ABCG2).
Römermann K; Helmer R; Löscher W
Neuropharmacology; 2015 Jun; 93():7-14. PubMed ID: 25645391
[TBL] [Abstract][Full Text] [Related]
8. Differential, strain-specific cellular and subcellular distribution of multidrug transporters in murine choroid plexus and blood-brain barrier.
Soontornmalai A; Vlaming ML; Fritschy JM
Neuroscience; 2006; 138(1):159-69. PubMed ID: 16361063
[TBL] [Abstract][Full Text] [Related]
9. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Baltes S; Gastens AM; Fedrowitz M; Potschka H; Kaever V; Löscher W
Neuropharmacology; 2007 Feb; 52(2):333-46. PubMed ID: 17045309
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of ABC and SLC transporters in the microvessels of developing rat brain.
Soares RV; Do TM; Mabondzo A; Pons G; Chhun S
Fundam Clin Pharmacol; 2016 Apr; 30(2):107-16. PubMed ID: 26662930
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein and breast cancer resistance protein expression and function at the blood-brain barrier and blood-cerebrospinal fluid barrier (choroid plexus) in streptozotocin-induced diabetes in rats.
Reichel V; Burghard S; John I; Huber O
Brain Res; 2011 Jan; 1370():238-45. PubMed ID: 21075088
[TBL] [Abstract][Full Text] [Related]
12. Lack of interactions between breast cancer resistance protein (bcrp/abcg2) and selected antiepileptic agents.
Cerveny L; Pavek P; Malakova J; Staud F; Fendrich Z
Epilepsia; 2006 Mar; 47(3):461-8. PubMed ID: 16529607
[TBL] [Abstract][Full Text] [Related]
13. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
Marroni M; Marchi N; Cucullo L; Abbott NJ; Signorelli K; Janigro D
Curr Drug Targets; 2003 May; 4(4):297-304. PubMed ID: 12699350
[TBL] [Abstract][Full Text] [Related]
14. Development of a humanized in vitro blood-brain barrier model to screen for brain penetration of antiepileptic drugs.
Cucullo L; Hossain M; Rapp E; Manders T; Marchi N; Janigro D
Epilepsia; 2007 Mar; 48(3):505-16. PubMed ID: 17326793
[TBL] [Abstract][Full Text] [Related]
15. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells.
Sakata S; Fujiwara M; Ohtsuka K; Kamma H; Nagane M; Sakamoto A; Fujioka Y
Oncol Rep; 2011 Feb; 25(2):333-9. PubMed ID: 21165575
[TBL] [Abstract][Full Text] [Related]
16. Modulation of transendothelial permeability and expression of ATP-binding cassette transporters in cultured brain capillary endothelial cells by astrocytic factors and cell-culture conditions.
Török M; Huwyler J; Gutmann H; Fricker G; Drewe J
Exp Brain Res; 2003 Dec; 153(3):356-65. PubMed ID: 14610630
[TBL] [Abstract][Full Text] [Related]
17. Interactions between the dopamine agonist, bromocriptine and the efflux protein, P-glycoprotein at the blood-brain barrier in the mouse.
Vautier S; Lacomblez L; Chacun H; Picard V; Gimenez F; Farinotti R; Fernandez C
Eur J Pharm Sci; 2006 Feb; 27(2-3):167-74. PubMed ID: 16263252
[TBL] [Abstract][Full Text] [Related]
18. Expression of ATP-binding cassette transporters at the inner blood-retinal barrier in a neonatal mouse model of oxygen-induced retinopathy.
Tagami M; Kusuhara S; Honda S; Tsukahara Y; Negi A
Brain Res; 2009 Aug; 1283():186-93. PubMed ID: 19505448
[TBL] [Abstract][Full Text] [Related]
19. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches.
Leandro K; Bicker J; Alves G; Falcão A; Fortuna A
Pharmacol Res; 2019 Jun; 144():357-376. PubMed ID: 31051235
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the immortalized human brain capillary endothelial cell line BB19 as a human cell culture model for the blood-brain barrier.
Kusch-Poddar M; Drewe J; Fux I; Gutmann H
Brain Res; 2005 Dec; 1064(1-2):21-31. PubMed ID: 16289483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
